Sara Bonstein serves as the Chief Financial Officer at Insmed Incorporated (INSMED INC), a global biopharmaceutical company focused on developing and commercializing therapies for patients with rare diseases. In her role as CFO, Sara is responsible for overseeing the financial strategy and operations of the company, ensuring its financial health and sustainability as it continues to grow and bring new treatments to market. Her leadership has been instrumental in guiding Insmed through periods of significant growth and development, particularly in the areas of financial planning, investor relations, and strategic partnerships. Before joining Insmed, Sara Bonstein held several key financial positions at major corporations, showcasing her extensive experience and expertise in the field. She previously served as the Senior Vice President of Finance and Investor Relations at Bausch Health Companies Inc., where she played a critical role in managing the company's financial communications and strategy. Prior to that, Sara spent over a decade at Allergan plc, rising through the ranks to become the Vice President of Investor Relations and Corporate Affairs. During her tenure at Allergan, she was recognized for her ability to effectively communicate complex financial information to investors and stakeholders, helping to drive the company's valuation and growth. Sara's strategic financial acumen and leadership skills have made her a valuable asset to Insmed, where she continues to contribute to the company's mission of improving the lives of patients with rare diseases.